How this Biotech Company is Bringing Software to Big Pharma

Computer-aided Drug Discovery is a Growing Field

Since completing a 2013 licensing deal with UM Ventures for technology that brings computers into the process of pharmaceutical drug discovery,SilcsBio has been growing its product offerings and sales.

Now, the company is getting a boost from the federal government. The company was awarded a Phase II Small Business Innovation Research (SBIR) award for $1.2 million, CEO Ken Malone said via email.

The funding from the National Institutes of Health will provide capital for the company to improve its capabilities in Computer-Aided Drug Design (CADD). The company’s existing products contain algorithms that map proteins, allowing specialists to test how they will perform with potential drugs that pharmaceutical companies are developing.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect